NCT04350281View on ClinicalTrials.gov

Double Therapy With IFN-beta 1b and Hydroxychloroquine

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 9, 2020

Primary Completion Date

July 1, 2020

Study Completion Date

July 7, 2020

Conditions
COVID
Interventions
DRUG

Interferon Beta-1B

Daily subcutaneous injection of interferon β-1b 1mL (0.25mg; 8 million IU) consecutively on day 1 to day 3

DRUG

Hydroxychloroquine

Hydroxychloroquine 800mg on day 1, then 400mg daily for 2 days

Trial Locations (1)

852

The University of Hong Kong, Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT04350281 - Double Therapy With IFN-beta 1b and Hydroxychloroquine | Biotech Hunter | Biotech Hunter